NOS3 and melanoma: In the presence of L-NAME, a preferentially eNOS inhibitor, the NO levels were decreased in WM1552C RGP (Figure S1A) and WM983B metastatic melanoma cells (Figure S2A), indicating that this isoform is a source of NO in these cells.